Sumatriptan succinate and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is found among people who take Sumatriptan succinate, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Sumatriptan succinate and have Intestinal obstruction. It is created by eHealthMe based on reports of 7,581 people who have side effects when taking Sumatriptan succinate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

7,581 people reported to have side effects when taking Sumatriptan succinate.
Among them, 12 people (0.16%) have Intestinal obstruction.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 7,930 Sumatriptan succinate users for its effectiveness, alternative drugs and more.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 3,019 drugs and 2,505 conditions by eHealthMe.

Number of Sumatriptan succinate and Intestinal obstruction reports submitted per year:

Could Sumatriptan succinate cause Intestinal obstruction?

Gender of people who have Intestinal obstruction when taking Sumatriptan succinate *:

female: 100 %
male: 0.0 %

Age of people who have Intestinal obstruction when taking Sumatriptan succinate *:

Common drugs people take besides Sumatriptan succinate *:

Common side effects people have besides Intestinal obstruction *:

Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 5 people, 41.67%
Anaemia (lack of blood): 5 people, 41.67%
High Blood Pressure: 4 people, 33.33%
Joint Pain: 3 people, 25.00%
Fatigue (feeling of tiredness): 3 people, 25.00%
Constipation: 3 people, 25.00%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 25.00%
Hypotension (abnormally low blood pressure): 3 people, 25.00%
Breathing Difficulty: 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 3 people, 25.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 25.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 16.67%
Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 16.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 16.67%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 8.33%
Immunodeficiency Common Variable: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and have Intestinal obstruction?

Check whether Intestinal obstruction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Intestinal obstruction treatments and more:

Intestinal obstruction (51,409 reports)

COVID vaccines that are related to Intestinal obstruction:

Common drugs associated with Intestinal obstruction:

All the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (3,019 drugs)

Common conditions associated with Intestinal obstruction:

Crohn's disease: 10,119 reports
High blood pressure: 2,265 reports
Pain: 1,840 reports
Acne: 1,646 reports
Rheumatoid arthritis: 1,604 reports

All the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,505 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate (the active ingredients of Sumatriptan succinate) and Sumatriptan succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.